Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CT-AI Breast Cancer Opportunistic Screening Health Examination Study

NCT: NCT07809698 · NOT_YET_RECRUITING

NCT IDNCT07809698
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2030-02-28
SponsorThe First Affiliated Hospital with Nanjing Medical University (OTHER)
First posted
Last updated

Brief Summary

This study evaluates the clinical utility of a locked chest CT artificial intelligence model for opportunistic breast cancer screening among women undergoing health examinations. The study includes a retrospective validation phase and a prospective single-arm implementation phase. AI analyzes existing non-contrast chest CT images without additional CT examinations. Clinical physicians make further evaluation decisions based on AI outputs, imaging findings, ultrasound results and clinical information.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑